A business in context

NBIX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-02 · 0001079462-26-000008

  2. 4 · Ownership change

    Report date 2026-08-04 · 0001894425-26-000018

  3. 8-K/A · Current report

    Report date 2026-05-14 · 0001193125-26-328470 · Items 9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000914475-26-000037

  5. 4 · Ownership change

    Report date 2026-07-28 · 0001533568-26-000012

  6. 8-K · Current report

    Report date 2026-07-30 · 0000914475-26-000035 · Items 2.02,9.01

  7. 4 · Ownership change

    Report date 2026-07-10 · 0001965808-26-000013

  8. 4 · Ownership change

    Report date 2026-07-09 · 0001504783-26-000017

  9. 4 · Ownership change

    Report date 2026-07-07 · 0001965808-26-000011

  10. 4 · Ownership change

    Report date 2026-06-26 · 0001504783-26-000015

  11. 4 · Ownership change

    Report date 2026-06-05 · 0001894425-26-000014

  12. 8-K · Current report

    Report date 2026-05-27 · 0000914475-26-000029 · Items 5.02,5.07

  13. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-228013 · Items 1.01,2.01,2.03,7.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000914475-26-000026

  15. 8-K · Current report

    Report date 2026-05-05 · 0000914475-26-000025 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-04-15 · 0000914475-26-000015

  17. 8-K · Current report

    Report date 2026-04-05 · 0001193125-26-142904 · Items 1.01,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0000914475-26-000007

  19. 8-K · Current report

    Report date 2026-02-11 · 0000914475-26-000006 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2025-11-21 · 0000914475-25-000186 · Items 5.02,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000914475-25-000181

  22. 8-K · Current report

    Report date 2025-10-28 · 0000914475-25-000180 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000914475-25-000158

  24. 8-K · Current report

    Report date 2025-07-30 · 0000914475-25-000157 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-05-30 · 0000914475-25-000139 · Items 5.02,9.01

  26. 8-K · Current report

    Report date 2025-05-21 · 0000914475-25-000120 · Items 5.02,5.07

  27. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000914475-25-000100

  28. 8-K · Current report

    Report date 2025-05-05 · 0000914475-25-000099 · Items 2.02,9.01

  29. DEF 14A · Proxy statement

    Report date 2025-04-09 · 0000914475-25-000091

  30. 8-K · Current report

    Report date 2025-04-02 · 0000914475-25-000081 · Items 5.02,7.01,9.01

  31. 10-K · Annual report

    Report date 2024-12-31 · 0000914475-25-000037

  32. 8-K · Current report

    Report date 2025-02-06 · 0000914475-25-000034 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-01-24 · 0000914475-25-000006 · Items 1.01,7.01,9.01

  34. 8-K · Current report

    Report date 2024-12-20 · 0000914475-24-000229 · Items 8.01

  35. 8-K · Current report

    Report date 2024-10-31 · 0000914475-24-000214 · Items 8.01

  36. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000914475-24-000211

  37. 8-K · Current report

    Report date 2024-10-30 · 0000914475-24-000210 · Items 2.02,9.01

  38. SC 13G · Ownership disclosure

    0000093751-24-000783

  39. 8-K · Current report

    Report date 2024-10-11 · 0000914475-24-000206 · Items 5.02

  40. 8-K · Current report

    Report date 2024-08-28 · 0000914475-24-000199 · Items 7.01,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 21 transaction rows21SGrant / award: 12 transaction rows12AExercise / conversion: 42 transaction rows42MTax / exercise payment: 1 transaction rows1FGift: 1 transaction rows1G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

77 matching transaction rows. Showing 51–77.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-27
2026-05-29
MORROW GEORGE JA · Grant / award
Acquired
Restriced Stock Unit
Derivative security
2567.00.0
2026-05-26
2026-05-28
Boyer David W.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3888.0156.64
2026-05-21
2026-05-21
Mercier JohannaM · Exercise / conversion
Acquired
Common Stock3318.00.0
2026-05-21
2026-05-21
Mercier JohannaM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
3318.00.0
2026-05-21
2026-05-21
Norwalk Leslie VM · Exercise / conversion
Acquired
Common Stock1659.00.0
2026-05-21
2026-05-21
Norwalk Leslie VM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
1659.00.0
2026-05-21
2026-05-21
Sharp ShaliniM · Exercise / conversion
Acquired
Common Stock1659.00.0
2026-05-21
2026-05-21
Sharp ShaliniM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
1659.00.0
2026-05-21
2026-05-21
RASTETTER WILLIAM HM · Exercise / conversion
Acquired
Common Stock3318.00.0
2026-05-21
2026-05-21
RASTETTER WILLIAM HM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
3318.00.0
2026-05-21
2026-05-21
POON CHRISTINE AM · Exercise / conversion
Acquired
Common Stock3318.00.0
2026-05-21
2026-05-21
POON CHRISTINE AM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
3318.00.0
2026-05-21
2026-05-21
POPS RICHARD FM · Exercise / conversion
Acquired
Common Stock3318.00.0
2026-05-21
2026-05-21
POPS RICHARD FM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
3318.00.0
2026-05-21
2026-05-21
LYONS GARY AM · Exercise / conversion
Acquired
Common Stock1659.00.0
2026-05-21
2026-05-21
LYONS GARY AM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
1659.00.0
2026-05-21
2026-05-21
SHERWIN STEPHEN AM · Exercise / conversion
Acquired
Common Stock3318.00.0
2026-05-21
2026-05-21
SHERWIN STEPHEN AM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
3318.00.0
2026-05-21
2026-05-21
MORROW GEORGE JM · Exercise / conversion
Acquired
Common Stock3318.00.0
2026-05-21
2026-05-21
MORROW GEORGE JM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
3318.00.0
2026-05-19
2026-05-21
GORMAN KEVIN CHARLES
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock205088.043.24
2026-05-19
2026-05-21
GORMAN KEVIN CHARLES
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock245088.0154.33
2026-05-19
2026-05-21
GORMAN KEVIN CHARLES
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option
Derivative security
205088.00.0
2026-05-15
2026-05-18
POPS RICHARD F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15000.0157.65
2026-05-15
2026-05-18
POPS RICHARD F
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock15000.047.89
2026-05-15
2026-05-18
POPS RICHARD F
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option
Derivative security
15000.00.0
2026-05-12
2026-05-14
Norwalk Leslie V
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3810.0155.01

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000914475NEUROCRINE BIOSCIENCES INC

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300FECER0XBN49756
GLEIF legal name
Neurocrine Biosciences, Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2026-07-29T18:14:48Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Neurocrine Biosciences · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$2.36B$2.51B
2023-12-31$1.89B$2.07B
2022-12-31$1.49B$1.70B
2021-12-31$1.13B$1.40B
2020-12-31$1.05B$1.35B
2019-12-31$788.10M$1.03B
2018-12-31$451.20M$599.97M
2017-12-31$161.63M$220.17M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗